Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NIH seeks to license invention related to compounds inducing apoptosis

Oct. 25, 1996

Japanese researchers disclose anticancer applications of the E1AF gene

Oct. 25, 1996

NIH seeks licensees for novel laminin molecule that lacks affinity for collagen IV

Oct. 25, 1996

GV-1301 and GV-1302 available for licensing

Oct. 25, 1996

Follow-up confirms safety of PN-27.1

Oct. 25, 1996

New antitumor agent from Banyu

Oct. 25, 1996

CRC Technology reports antitumor activity of DF-203

Oct. 25, 1996

DAG analogues as potent PKC agonists available for licensing

Oct. 25, 1996

Hybridon anti-VEGF antisense compounds for neovascularization disorders

Oct. 25, 1996

NIH offers peptides with OMT residues as potential therapeutic agents

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.